Internal Server Error

Diamens - About the company

Diamens is a seed company based in Linz (Austria), founded in 2024. It operates as a Developer of a test for endometriosis using menstrual blood samples. Diamens has raised an undisclosed amount in funding. The company has 16 active competitors, including 8 that are funded. Its top competitors include companies like Hera Biotech, DotLab and EndoGene.Bio.

Company Details

Developer of a test for endometriosis using menstrual blood samples. The company is developing a test kit for self-collection of menstrual blood. The sample is sent to a partner laboratory, and results are available within days. The aim is to provide a readily accessible, non-invasive method for endometriosis diagnosis.
Email ID
*****@diamens.org
Key Metrics
Founded Year
2024
Location
Linz, Austria
Stage
Seed
Latest Funding Round
Investors
Ranked
Similar Companies
Sign up to download Diamens' company profile

Diamens's funding and investors

Diamens has raised funding over 1 round. Its latest funding round was a Seed round on Mar 17, 2026 for $*****. 4 investors participated in its latest round. Diamens has 4 institutional investors.

Here is the list of recent funding rounds of Diamens:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Mar 17, 2026
3296738
Seed
1062139
7993677
1823331
7632571
lockAccess funding benchmarks and valuations. Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Diamens's Competitors and alternates

Top competitors of Diamens include Hera Biotech, DotLab and EndoGene.Bio. Here is the list of Top 10 competitors of Diamens, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Hera Biotech
Hera Biotech
2020, San Antonio (United States), Seed
Developer of diagnostic test kit for endometriosis
$3.21M
49/100
2nd
Logo for DotLab
DotLab
2016, Branford (United States), Series A
Provider of a molecular diagnostic testing tool for endometriosis in women
$10M
49/100
3rd
Logo for EndoGene.Bio
EndoGene.Bio
2022, Paris (France), Seed
Developer of non-invasive endometriosis diagnostic tests
-
35/100
4th
Logo for Diamens
Diamens
2024, Linz (Austria), Seed
Developer of a test for endometriosis using menstrual blood samples
-
32/100
5th
Logo for CiceroDx
CiceroDx
2015, Huntington Beach (United States), Funding Raised
Provider of molecular diagnostics for women's health
-
 
32/100
6th
Logo for Juneau Biosciences
Juneau Biosciences
2007, Salt Lake City (United States), Series A
Diagnostics for women's health using population genetics and genomics
$7.89M
31/100
7th
Logo for Endodiag
Endodiag
2011, Paris (France), Series A
Developer of endometriosis diagnostic solutions
$5.54M
31/100
8th
Logo for AIMA Laboratories
AIMA Laboratories
2021, Hamilton (Canada), Funding Raised
Developer of at-home blood test for gynecological health
-
25/100
9th
Logo for Genie Fertility
Genie Fertility
2024, United Kingdom, Funding Raised
Developer of a platform studying molecular biomarkers in the uterus lining
-
24/100
10th
Logo for V-CHECK
V-CHECK
2017, Zhubei (Taiwan), Unfunded
Developer of in vitro diagnostic products for women health
-
-
24/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Diamens's competitors? Click here to see the top ones

Diamens's Investments and acquisitions

Diamens has made no investments or acquisitions yet.

Reports related to Diamens

Here is the latest report on Diamens's sector:

News related to Diamens

Media has covered Diamens for 1 event in last 1 year.
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Diamens

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford